Use of flibanserin in the treatment of obesity
AssigneeSprout Pharmaceuticals, Inc.
InventorsAngelo Ceci, Marcus Schindler
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for the treatment of obesity and related diseases comprising the administration of a therapeutically effective amount of Flibanserin.
Claims12
A method of promoting, increasing or facilitating weight loss comprising administering to an individual in need thereof a therapeutically effective amount of filbanserin, or a pharmacologically acceptable acid addition salt thereof.
A method of inhibiting body weight gain comprising administering to an individual in need thereof a therapeutically effective amount of flibanserin, or a pharmacologically acceptable acid addition salt thereof.
A method of inhibiting or reducing appetite comprising administering to an individual in need thereof a therapeutically effective amount of flibanserin, or a pharmacologically acceptable acid addition salt thereof.
Dependencies are inferred from the claim text.